McNicoll Lewis & Vlak Downgrades Zalicus (ZLCS) to Hold
Tweet
Share
E-mailGet Alerts ZLCS Hot Sheet
Price: $1.18 --0%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
McNicoll Lewis & Vlak downgraded Zalicus (NASDAQ: ZLCS) from Buy to Hold with a price target of $1.00 following phase 2b trial results from Synavive which were statistically significant but missed a key secondary endpoint.
For an analyst ratings summary and ratings history on Zalicus click here. For more ratings news on Zalicus click here.
Shares of Zalicus closed at $1.39 yesterday.
For an analyst ratings summary and ratings history on Zalicus click here. For more ratings news on Zalicus click here.
Shares of Zalicus closed at $1.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- Jefferies Downgrades Pediatrix Medical Group (MD) to Hold
- CLSA Downgrades Infosys Ltd. (INFO:IN) (INFY) to Hold (3)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
